Arcus Biosciences (RCUS) Asset Utilization Ratio (2018 - 2026)
Arcus Biosciences (RCUS) posted quarterly Asset Utilization Ratio of 0.22 for Q1 2026, up 84.14% year-over-year from 0.12 in Q1 2025, and down 5.48% quarter-over-quarter from 0.23 in Q4 2025.
Arcus Biosciences (RCUS) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Arcus Biosciences' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.22 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 84.14% year-over-year to 0.22; the TTM figure through Mar 2026 stood at 0.22 (up 84.14% YoY), while the FY2025 annual figure was 0.22, down 6.1% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.22, down from 0.23 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.3 in Q3 2022, with the low at 0.08 in Q4 2022.
- The 5-year median for Asset Utilization Ratio is 0.2 (2024), against an average of 0.18.
- Peak annual rise in Asset Utilization Ratio reached 591.67% in 2022, while the deepest fall reached 73.61% in 2022.
- Arcus Biosciences' Asset Utilization Ratio stood at 0.08 in 2022, then increased by 5.21% to 0.09 in 2023, then surged by 140.73% to 0.21 in 2024, then gained by 11.01% to 0.23 in 2025, then fell by 5.48% to 0.22 in 2026.
- Business Quant data shows RCUS's Asset Utilization Ratio at 0.22 in Q1 2026, 0.23 in Q4 2025, and 0.23 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.12 |
| Mar 31, 2026 | 0.22 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | 0.23 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.20 |
| Jun 30, 2024 | 0.18 |
| Mar 31, 2024 | 0.18 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.10 |
| Jun 30, 2023 | 0.10 |
| Mar 31, 2023 | 0.09 |
| Dec 31, 2022 | 0.08 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.27 |
| Mar 31, 2022 | 0.25 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.04 |